FSP Annual Meeting 2022


The FSP’s 48th Annual Pathology Conference: Updates and Practical Approaches in Pathology will provide pathologists with education surrounding a wide range of topics and the opportunity to learn and adopt new strategies and tools to aid in the diagnosis and analysis of diseases.

The conference will provide practical updates and clinical pearls and pitfalls in the following topics:

  • GU Pathology
  • GI Pathology
  • Head and Neck Pathology

In addition, there will be education on additional topics during interactive read slides and microscopy sessions.

New This Year!
We are excited to announce that there will be a Rare and Interesting Case Session where community pathologists, junior faculty and trainees with a faculty mentor will be invited to submit their cases for presentation. Five cases will be chosen. Please visit the Rare and Interesting Case Competition tab for more information.  

2022 FSP Annual Conference

Personal Information

Contact Information

Registration Type *Discounts Cannot be Applied Retroactively

Proof of Training Status


Special Events Tickets

Guest Event Tickets
More Info
$75 each

Business Luncheon

I will attend the Business Luncheon on Saturday
Select a registration first to RSVP
More Info

I will NOT attend the Business Luncheon on Saturday
The Business Luncheon has been organized by the Florida Society Pathologists (FSP) and designed to update FSP members on current events and politics related specifically to the state of Florida.

FSP Poster Hall Registration

I am a resident or fellow and would like to compete in the Poster Competition
I am not a resident or fellow but would like to submit an abstract for the FSP Poster Hall
I am a resident or fellow who plans to submit a poster for the annual meeting, and I would like my poster to be considered for an oral podium presentation at the meeting during a designated session on the agenda. Note: This is a separate event from the Poster Competition.

Additional Products

Item Price
Fellowship Fair and Resident Forum
This event is free to attend but please check the box to RSVP.
Printed syllabus
A printed syllabus can be purchased for an additional cost at the time of registration. A printed syllabus is not provided unless purchased at the time of registration. A digital syllabus will be provided to all attendees who are registered at no additional cost.

Florida Society of Pathologists COVID-19 Policy and Waiver of Liability

The FSP is looking forward to returning to in-person educational events and is taking the health and wellbeing of our participants as our top priority. While participating in-person at the FSP Annual Pathology Conference on February 18-20, 2022 the FSP will follow suggested federal, state, and local preventive measures to reduce the spread of COVID-19; however, the FSP cannot guarantee that participants, attendees, exhibitors, vendors, staff, or others in attendance (“participants”) will not become infected with COVID-19. All participants will be asked to:

  1. Wear masks when and where required
  2. Practice social distancing when and where required
  3. Follow any pathway signage
  4. Follow good personal hygiene practices
  5. Practice self-monitoring & self-reporting
  6. Follow the requirements of the host hotel that are in place at the time of the meeting.
  7. Not travel to or attend the FSP meeting if you are sick or become sick
  8. Take reasonable precautions to ensure your own comfort

I understand the inherent risks of attending the FSP meeting and that I may be exposed to or infected by COVID-19. By attending the FSP meeting, I am acknowledging that exposure or infection may result in quarantine requirements, serious illness, permanent disability and/or death. I agree to follow all health and safety precautions for the FSP meeting. I also acknowledge that if I choose not to follow the health and safety precautions as outlined by the FSP, the meeting venue and other partners for the FSP, my registration may be canceled, and I may be removed from the meeting with no refund of any related expenses. I willingly agree to comply with the stated terms and conditions for participation as protection against COVID-19 including those outlined here for the FSP meeting.


Payment Information

Abstract Poster Submission #1
Poster Title
Author Name(s)
Financial Disclosures
Disclosure of Funding Support
Choose one of the following Topics



Jonathan Epstein, MD
Professor of Pathology, Urology, Oncology
Johns Hopkins Medicine
Baltimore, MD
Topic: GU Pathology


Elizabeth Anne Montgomery, MD
Professor of Pathology 
University of Miami
Miami, FL
Topic: GI Pathology


Bruce M. Wenig, MD
Chair and Senior Member, Department of Pathology 
Moffitt Cancer Center
Tampa, FL 
Topic: Head and Neck Pathology


David Andrews, MD
Associate Professor, Department of Pathology and Laboratory Medicine 
University of Miami Miller School of Medicine 
Miami, FL
Topic: COVID-related laboratory activities (variant tracking initiative)


Aziza Nassar, MD, MPH, MBA
Chair and Professor, Pathology and Laboratory Medicine 
Mayo Clinic and Foundation 
Jacksonville, FL
Topic: Breast Pathology Microscopy Session 


Zehra Ordulu, MD
Assistant Professor, Department of Pathology, Immunology and Laboratory Medicine
University of Florida 
Gainesville, FL
Topic: GYN Pathology Microscopy Session 


Elham Nasri, MD
Clinical Assistant Professor 
University of Florida
Gainesville, FL
Topic: What is new in the world of undifferentiated small round cell tumors


Marie L. Rivera-Zengotita, MD
Neuropathology Unit Director 
Clinical Associate Professor
University of Florida
Gainesville, FL
Topic: Mesenchymal-type tumors of the CNS: Revisiting the oldies and introducing new entities from the 2021 WHO classification 


Brian Stewart, MD
Clinical Assistant Professor 
University of Florida
Gainesville, FL
Topic: Poorly Differentiated Lung Tumors: When TTF-1/Napsin-A and p40 aren’t enough


Ronald Giffler, MD
Past President  
Florida Medical Association 
President and CEO
Fort Lauderdale, FL


Emily Volk, MD, MBA, FCAP
College of American Pathologists 
San Antonio, TX


Friday, February 18, 2022

10:30 AM - 12:00 PM
Approach and updates to mesenchymal-type tumors- Navigating the blue and spindled sea Educational Symposium-Hosted by The University of Florida- Gainesville
Brian Stewart, MD; Elham Nasri, MD; Marie L. Rivera-Zengotita, MD
12:00 PM - 1:00 PM
Non-CME Product Theater Lunch   
1:00 PM - 1:15 PM
1:15 PM - 2:15 PM
Diagnostic Challenges in Follicular Patterned Thyroid Neoplasms
Bruce M. Wenig, MD
2:15 PM - 3:15 PM
Squamous Cell Carcinoma of the Head and Neck: Precursor Lesions and Selective Subtypes
Bruce M. Wenig, MD
3:15 PM - 3:45 PM
Refreshment Break with Exhibitors and Poster Sessions  
3:45 PM - 4:45 PM
Pitfalls in the Biopsy Diagnosis of Salivary Gland Neoplasms Interactive Microscopy Session
Bruce M. Wenig, MD
4:45 PM - 5:30 PM
Interactive Read Slides Microscopy Session- GYN Pathology
Zehra Ordulu, MD
5:30 PM - 6:30 PM
Non-CME Product Theater  
6:30 PM - 7:30 PM
Welcome Reception with Exhibitors  

Saturday, February 19, 2022

7:00 AM - 8:00 AM
Continental Breakfast with Exhibitors and Poster Sessions   
7:00 AM - 7:45 AM
Non-CME Product Theater Breakfast   
7:00 AM - 8:00 AM
Resident Forum
Breakfast Served
8:00 AM - 8:15 AM
Morning Notes and Overview   
8:15 AM - 9:15 AM
The Anus is Not Always LAST
Elizabeth Anne Montgomery, MD
9:15 AM - 10:15 AM
Wicked Small Bowel Lesions, Mostly Neoplastic
Elizabeth Anne Montgomery, MD
10:15 AM - 11:00 AM
Refreshment Break with Exhibitors and Poster Sessions  
11:00 AM - 12:00 PM
My Favorite GI Tract Mesenchymal Lesions: Interactive Microscopy Session
Elizabeth Anne Montgomery, MD
12:00 PM - 1:45 PM
FSP Business Meeting and Awards Presentation
Ronald Giffler, MD; Emily Volk, MD, MBA, FCAP
1:45 PM - 2:30 PM
COVID-Related Laboratory Activities (variant tracking initiative)
David Andrews, MD
2:30 PM - 3:15 PM
Interactive Read Slides Breakout Session – Breast Pathology
Aziza Nassar, MD, MPH, MBA
3:15 PM - 4:15 PM
Rare and Interesting Cases  How to submit your case
4:30 PM - 5:30 PM
Fellowship Fair and Reception   
6:00 PM - 7:30 PM
College of American Pathologists (CAP) House of Delegates Reception   

Sunday, February 20, 2022

7:00 AM - 8:00 AM
Continental Breakfast with Exhibitors   
8:00 AM - 8:15 AM
Morning Notes and Overview   
8:15 AM - 9:15 AM
Update on Prostate Cancer Grading
Jonathan Epstein, MD
9:15 AM - 10:15 AM
Medicolegal Issues In GU Pathology
Jonathan Epstein, MD
10:15 AM - 11:00 AM
Refreshment Break with Exhibitors   
11:00 AM - 12:00 PM
GU Pathology Interactive Microscopy Session
Jonathan Epstein, MD
12:00 PM - 12:15 PM
Closing Remarks  
*Please note the agenda is subject to change   


Disney’s Grand Floridian Resort & Spa
4401 Floridian Way
Lake Buena Vista, Florida 32830
Room Rate: $329/night (plus tax)

To reserve your sleeping room you must FIRST register for the meeting. You will receive a special code and the reservations link to reserve your room after you have registered for the FSP Conference.

About Disney’s Grand Floridian Resort & Spa

Victorian elegance meets modern sophistication at this lavish Disney Resort hotel. Relax in the sumptuous lobby as the live orchestra plays ragtime, jazz and popular Disney tunes. Unwind outdoors, indulge in a luxurious massage and watch evening fireworks light up the sky over Cinderella Castle. Just one stop to Magic Kingdom park on the complimentary Resort Monorail, this timeless Victorian-style marvel evokes Palm Beach’s golden era.



FSP 2022 Annual Pathology Conference


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and the Florida Society of Pathologists. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Florida Medical Association designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statements of credit/participation will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claim credit form at www.flpath.org/claimcme.  If you have questions about this CME/CE activity, please contact the FSP at 904-309-6261. Credit must be claimed by March 2, 2022.


This activity is designed to meet the needs of practicing physicians, pathologists, and other specialists involved with pathology.

The field of pathology is constantly changing, and many of the most important advances in the field. In the setting of new technology, techniques and advancements in the field, practice gaps are inevitable. As such, pathologists require ongoing educational opportunities to stay current in order to maintain and improve their knowledge and competence in the field.


At the conclusion of this activity, all participants should be able to:

  • Describe grading rules for prostate cancer on needle biopsy and radical prostatectomy
  • Discuss grading rules for common prostate cancer variants and treated prostate cancer
  • Review the definition of malpractice and the overview of a lawsuit
  • Recognize various pathologic and clinical features of Genitourinary tumors
  • Recognize relevant entities in the differential diagnosis of various unusual Genitourinary tumors
  • Discuss common and less common anal neoplasms
  • Discuss differences between small bowel neoplasms and common mimics 
  • Review common misconceptions concerning the types of mast cell lesions
  • Recognize gastrointestinal tract mesenchymal lesions of the submucosa, muscularis propria, and mesentery
  • Distinguish the various types of mucosal nerve sheath tumors
  • Identify criteria for diagnosing and differentiating benign from malignant follicular patterned thyroid neoplasms\
  • Discuss the use and limitations of immunohistochemistry and molecular diagnostics in the diagnosis of follicular patterned thyroid neoplasms
  • Identify the criteria and clinical relevance of differentiated intraepithelial dysplasia of the upper aerodigestive tract
  • Recognize the various clinical and pathologic features for selective subtypes of squamous cell carcinoma of the head and neck
  • Recognize the diagnostic criteria for metastatic carcinoma to the cervical neck of unknown primary origin
  • Recognize various pathologic and clinical features of select salivary gland neoplasms
  • Discuss the role of immunohistochemistry and molecular pathology in the diagnosis and differential diagnosis of select salivary gland neoplasms
  • List the new mesenchymal, non-meningothelial CNS tumors introduced in the 2021 WHO Classification of CNS Tumors
  • Recognize the use of molecular techniques in diagnosis of undifferentiated small round cell neoplasms and clinical implication of proper classification of these tumors
  • Identify the appropriate workup for poorly differentiated lung tumors
  • Recognize pathologic and clinical features of various gynecologic entities
  • Recognize diagnostic features of lesions of the breast
  • Appraise unique pathology cases
  • Discuss COVID-related laboratory activities and COVID variant tracking

This activity is supported by an educational grant from Olympus. This activity is supported by in-kind product from Olympus. All commercial support and educational grants will be communicated to attendees in advance of the meeting.



  • Qihui Jim Zhai, MD- Has nothing to disclose.
  • Stephen Vernon, MD- Has nothing to disclose.
  • Meg Neal, MD- Has nothing to disclose.
  • Carmen Gomez-Fernandez, MD- Has nothing to disclose.
  • Morton Levitt, MD- Has nothing to disclose.
  • Jesse Kresak, MD- Has nothing to disclose.
  • Vatsal Patel, MD- Has nothing to disclose.
  • Philip Robinson, MD- Has nothing to disclose.
  • Marilyn Bui, MD- Has nothing to disclose.


  • Jonathan Epstein, MD- Has nothing to disclose.
  • Elizabeth Anne Montgomery, MD- Has nothing to disclose.
  • Bruce M. Wenig, MD- Has nothing to disclose.
  • David Andrews, MD- Has nothing to disclose.
  • Aziza Nassar, MD, MPH, MBA- Has nothing to disclose.
  • Zehra Ordulu, MD- Has nothing to disclose.
  • Elham Nasri, MD- Has nothing to disclose.
  • Marie L. Rivera-Zengotita, MD- Has nothing to disclose.
  • Brian Stewart, MD- Has nothing to disclose.
It is the policy of the Florida Medical Association (FMA) to ensure independence, objectivity and scientific rigor in all approved CME content. CME faculty must present evidence-based data, clarify off-label product use and disclose all relevant financial relationships to the audience. The ideas and opinions expressed during jointly provided events do not necessarily reflect those of the FMA, and the FMA’s approval of course content for AMA PRA Category 1 Credits™. does not constitute an endorsement of the ideas, positions or statements contained therein.  Every effort has been made to ensure that all information provided by the joint provider is accurate and current. However, FMA does not accept responsibility for errors or omissions and accepts no liability for any resulting loss or damage. Attendees agree to participate in this CME activity with full knowledge and awareness that they waive any claim they may have against the FMA for injury or other damage that may result in any way from their participation in this activity.


    Exhibitors at the 2022 FSP Annual Pathology Conference will connect with over 250 pathologists and engage in over 15 hours of face-to-face time with attendees.

    Other benefits include:

    • pre and post attendee lists
    • acknowledgement on virtual exhibit hall online, meeting signage, and mobile app
    • maximize exposure with prize giveaways and breaks scheduled in the exhibit hall
    • 2 complimentary badges to access all exhibit hall activities and all educational sessions

    Exhibitor/Sponsor RegistrationExhibitor/Sponsor Prospectus

    Past FSP Exhibitor Testimonials

    We feel that the quality of speaker presentations, discussions, and organization at FSP is phenomenal. We look forward to attending in 2022.

    – Aiforia

    The 2021 FSP Meeting has been one of the best meetings I have attended as an exhibitor. The atmosphere is very welcoming as an exhibitor. I feel part of the meeting as opposed to an outsider. It is an atmosphere where I have felt we are one with the pathologists working together to help their patients – Cindy S. May, MT (ASCP)

    – AstraZeneca

    A great conference from all aspects. We met very interesting people and had good conversations. Good flow to conference. Very organized. Will be back next year!

    – Michigan Medicine Labs




    Resident Forum 
    Saturday, February 19
    7:00 am - 8:30 am

    The FSP's Resident and Fellow Committee is excited to announce the addition of an exciting new event, the FSP Resident's Forum. This event is open to all residents attending the FSP Conference. Join your resident colleagues for an informal and open discussion and hear from FSP leaders and mentors on important society updates and valuable benefits including advocacy, new in practice tips and networking. Attendees of the forum will also have the opportunity to address their questions and seek insight on leadership opportunities in the society and in their professional development beyond graduation. There is no fee to attend!

    Breakfast will be served!


    • The Importance of Advocacy 
    • New in Practice Hot Topics
    • Networking within the FSP and FSP Mentorship Program 

    Fellowship Fair
    Saturday, February 19
    4:30 pm - 5:30 pm 

    Back by popular demand, FSP will hold a fellowship fair and reception showcasing the various fellowship programs in Florida. The fair will take place on Saturday, February 19 from 4:30-5:30 pm. This is a personalized and unique opportunity to learn about the fellowship programs available to pathology residents and fellows in the state of Florida. All prospective fellows are encouraged to attend!  There is no fee to attend! 

    College of American Pathologists (CAP) House of Delegates Reception
    Saturday, February 19
    6:00 pm - 7:30 pm 

    Join the Florida Delegation for the College of American Pathologists (CAP) House of Delegates Reception in St. Augustine A at the conference center on Saturday, February 19 from 6:00-7:30 pm. Drinks and light appetizers will be available for your enjoyment. This reception is a chance to network with the Florida Delegation and CAP leadership. The Florida Delegation welcomes your ideas and thoughts on the important issues facing you and your practice. There is no fee to attend!




    Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.



    Aiforia equips pathologists and scientists in preclinical, academic, and clinical labs with the most powerful deep learning artificial intelligence and cloud-based technology to increase the speed, accuracy and consistency of analyzing large and complex medical images across a variety of fields from oncology to neuroscience. Aiforia is composed of an ideal mix of scientists experienced in a variety of medical areas from pathology to cancer diagnostics, software developers who collectively hold over 100 years’ experience in artificial intelligence, and a business team with backgrounds in the pharmaceutical and biotechnology industries.



    APS Medical Billing is a premier billing firm that provides expert billing and practice management solutions to pathology and laboratory practices nationwide. APS’ clients range in size from a single-physician practice to large, multi-site academic departments, reference and independent labs. The scope of our billing services and proven strategies allow APS to effectively bill for professional, technical and global components of anatomic and clinical pathology services. 



    Arkana Laboratories is a center for esoteric pathology focused on one thing: improving care for patients.  We are committed to providing doctors with the highest quality, clinicopathologic discussion possible. We do this by providing world-class diagnostics for renal pathology, neuropathology, serology, and molecular (genomic) services.  Biopsy reports are final (including EM) the same day the tissue arrives at our lab, supplying nephrologists with the needed data to begin treatment plans immediately.



    Our ambition is to push the boundaries of science to change the practice of medicine and transform the lives of cancer patients. We target the underlying biology of cancer in Immuno-Oncology, Tumor Drivers/Resistance, DNA Damage Response and Antibody Drug Conjugates. Utilizing precision medicine and biomarker-driven indications we look to dramatically improve five-year survival. Our focus on early disease stages and relapsed patients is to 1) identify and treat patients earlier with curative intent; and 2) support relapsed and refractory patients by tackling primary or acquired resistance.



    Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.



    Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit www.CarisLifeSciences.com or follow us on Twitter (@CarisLS).



    Cleveland Clinic Laboratories is dedicated to providing high-quality, clinically impactful pathology and laboratory diagnostic services combined with readily available consultation from experienced pathologists and laboratory scientists. Our laboratories offer excellence in coagulation, flow cytometry, hematopathology, molecular testing and cytogenomics,  and microbiology as well as subspecialty services in anatomic pathology. This approach ensures that every specimen submitted will be evaluated by a pathologist with a high level of diagnostic expertise in that specific field of pathology.




    As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. 


    CSI Laboratories is a cancer diagnostics laboratory known for its quality, state-of-the-art laboratory facility, and experienced staff. Our in-house medical team works closely with pathologists, oncologists, and technicians to provide comprehensive global and technical laboratory results throughout the United States. CSI Laboratories offers a full range of comprehensive cancer tests including flow cytometry, cytogenetic analysis, FISH, immunohistochemistry, molecular genetics, and consultations in the areas of hematopathology and surgical pathology.


    Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.



    Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.


    General Data Healthcare


    Streamline workflow efficiencies and processes, eliminate errors and provide the best patient care with healthcare solutions from General Data. With our broad range of resources, including solutions for histology, positive patient identification, mobility, data capture and labeling, hospital and laboratory staff can use these technologies to do what they do best: deliver optimal outcomes and the best possible care.



    GenPath Oncology provides leading expertise in cancer diagnostics and offers a comprehensive portfolio to provide a single source solution laboratory for cancer patients’ needs. GenPath is backed by a team of specialized pathologists and has experience in providing diagnostic oncology solutions, from routine clinical and special coagulation testing to complex genomic testing for tumor sequencing and hereditary cancer syndromes. GenPath offers oncologists and pathologists a variety of diagnostic solutions including morphological analysis, immunohistochemistry, FISH, flow cytometry, karyotyping, molecular analysis, and next generation sequencing.



    ImagineSoftware is the leading provider of medical billing automation software and revenue cycle management applications. Offering powerful technology solutions for medical billing offices, practices, and hospitals for over 21 years, ImagineSoftware currently serves more than 48,000 physicians. ImagineSoftware solutions improve financial efficiency, build provider reputation, and ultimately improve the patient experience. For more information, visit ImagineTeam.com and follow us on Twitter @ImagineTeam.


    Innovative Science Press believes that all physicians deserve access to quality and affordable medical training to help their patients. For this reason, our books are written by some of the most prominent in the field and are reasonably priced. Although there are many excellent sources for learning diagnostic pathology, those directed at residents, fellows, and practicing pathologists, are too simplified to be practical for daily work, and many other texts assume a foundation of more knowledge than many of us have as we begin to learn about a new area of diagnostic pathology. The pathology survival guides aim to help not only residents and fellows but also practicing pathologists who begin to tackle an organ system unfamiliar to them or refresh knowledge on a particular topic. These volumes are practical, concise, and full of excellent illustrations.


    Interpace Diagnostics


    Molecular testing for indeterminate thyroid nodules are not all the same. ThyGeNEXT / ThyraMIR is the only testing platform that utilizes both mutational and microRNA markers to aid patient management. MicroRNA classification complements cytology and mutational analysis as well as risk-stratified patients with weak driver mutations, including RAS. 



    MagMutual is a provider of Medical Malpractice insurance and practice solutions, including patient safety services to over 25,000 physicians and hospitals.


    MedReceivables Advisor, LLC


    MedReceivables Advisor, LLC is a full service outsourcing medical billing company for the hospital based physician. Our company provides complete accounts receivable management services for hospital-based physicians. 



    As a CLIA-certified/CAP accredited full-service laboratory of over 30 years, Michigan Medicine Laboratories combines the scientific rigor and infrastructure investment of a top academic research institution with the efficiency, flexibility, and responsiveness of a private reference lab. Our menu consists of over 1,800 tests and 60 expert consultants within 18 subspecialties available across the country. Partnering with Michigan Medicine Laboratories means gaining acces to one of the largest, most productive pathology enterprises in academic medicine, with faculty equally passionate about scientific discovery and service excellence. By making nationally recognized faculty and state-of-the-science technology easily accessible, we help you meet your practice's needs for on-time, accurate pathology results. 


    Management Services Network, LLC (MSN) is a privately held company that provides comprehensive and proactive billing, accounts receivable and practice management services to radiology practices nationwide. The breadth and depth of MSN's experience and involvement in the radiology environment provides clients with confidence, trust and results. MSN provides services beyond the typical billing company, such as patient satisfaction surveys, and has also been approved by CMS as a Qualified Clinical Data Registry (QCDR) for MIPS measure creation, submission and reporting. Learn more at msnllc.com.



    Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease.




    Signatera™ is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer management. 



    NeoGenomics is a Florida-based premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic, and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the US and offer global capabilities with laboratories in Switzerland and Singapore. 


    Billing and Revenue Cycle Management 



    Quest Diagnostics


    Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management.  We serve half of the physicians and hospitals in the United States. 



    Our goal is to build awareness around an aggressive and deadly hematologic malignancy called Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).  There is a newly approved therapy for BPDCN and we aim to shorten the time to diagnosis so patients can be placed on appropriate therapy in a timely manner.



    University of Florida Health Pathology Laboratories is the largest academic outreach pathology laboratory in Florida, offering comprehensive pathology services to hospitals and physician groups throughout the state.  



    Vachette provides revenue strategyrevenue consulting and revenue insurance for independent laboratories, hospital outreach laboratories, esoteric laboratories, private pathology practices, individual hospitals and health systems.




    Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve patient care when diagnostic test results are uncertain. Our tests leverage innovations in genomic technology and machine learning to enable a significantly more confident diagnosis than currently possible in challenging diseases such as thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. We are creating new standards of care in the diagnosis of these diseases by enabling more patients to avoid unnecessary invasive procedures, speeding time to diagnosis and removing costs from the healthcare system. 


    Coming soon

    FSP Welcomes Submissions for Poster Hall and Poster Competition

    The Florida Society of Pathologists (FSP) Poster Review Committee invites the submission of posters for inclusion in the Poster Hall during the FSP’s Annual Pathology Conference taking place on February 18-20, 2022 at Disney’s Grand Floridian Resort & SpaThe purpose of the FSP Poster Hall is to stimulate research, provide a venue to share innovative and effective educational programs, showcase unique research projects, and to encourage networking among pathologists.


    Who Can Submit?
    All pathologists are invited to submit case-based posters or research-based posters for inclusion in the Poster Hall. Residents and fellows are eligible to compete in the FSP Poster Competition for prizes.


    Poster Submission Deadline
    January 7, 2022
    11:59 pm EST


    Poster Competition Eligibility
    Residents and fellows who are enrolled in a full-time approved training program in pathology or sub-specialty of pathology in the state of Florida are invited to submit and are eligible to participate in the FSP Poster Competition.


    Poster Competition Presentation Process and Awards
    Posters will be pre-judged and selected by FSP judges based on quality, innovation, approach/design, and visuals. Posters will be judged twice and are subject to an additional preliminary review to determine eligibility. If judges deem that changes need to be made for posters to be eligible for presentation, lead authors will be contacted by email. The first judging will be done before the conference, and it will be a blind review. The second judging will be conducted during the live poster sessions during the conference on either Friday, February 18 or Saturday, February 19. The scores from both judging sessions will be combined to determine the winners. The first-place winner will receive $500, the second-place winner will receive $250, and the third-place winner will receive $150.

    To be considered for the Poster Competition and awards, you must:

    1. Be a resident or fellow in the state of Florida
    2. Be available to present your poster live on either Friday, February 18 or Saturday, February 19 in Orlando, Florida
    3. Register and pay the poster fee of $50/per poster
    4. Submit your poster by the submission deadline.

    Winners of the Poster Competition will be announced, and prizes will be awarded during the FSP Business Meeting on Saturday, February 19, 2022.


    Poster Submission Instructions
    Please read through the submission instructions below before preparing your poster:

    1. Submit your poster on this website through the online submission portal below
    2. Register for the Conference and pay the meeting registration fee and poster fee


    General Information and Policies:

    • Lead authors on all submissions are required to register for the conference and pay the applicable registration fee.
    • Residents and fellows participating in the Poster Competition are required to present their poster during the live poster sessions for judging in the Competition.
    • Up to four posters may be submitted.
    • It is the responsibility of the submitter to ensure that his/her poster is submitted correctly.
    • Full disclosure of all authors must be provided by the time of submission. Any failure to fully comply with this requirement may result in the poster being withdrawn.
    • If judges deem that a poster must be edited or updated to be eligible for presentation, lead authors will be contacted by email.


    Content Guidelines
    Poster entries can only be accepted electronically and must adhere to the following guidelines:

    • Posters must have one central theme, include essential data and test, and be visually appealing.
    • Posters must be proofread carefully to avoid errors before submission.
    • Posters must contain generic drug names only.
    • Posters must be submitted in clear English with accurate grammar and spelling of quality suitable for publication.
    • Lead and secondary authors must disclose all financial relationships.
    • Any funding support for the research must be disclosed.
    • Encore research is not eligible for submission.
    • A maximum of 4 references are allowed.


    You will be asked for the following:

    • Short poster title (40-character title for use on onsite signage)
    • Author name(s)
    • Financial disclosures
    • Disclosure of funding support
    • Topic

    The online poster submission does not allow you to save and return to resume later. Therefore, before starting your submission, have all materials and information ready. After the poster is submitted, you will receive an automated email to confirm your submission. If you do not receive the email within 24 hours, please contact the FSP office at posters@flpath.org or call Erin Corrales at 904-309-6204.


    Poster Topics
    The poster must relate to an appropriate topic in the field of pathology. Poster authors will be required to indicate which topic BEST matches the content of their poster. Topics are:

    • Blood Banking/Transfusion Medicine
    • Chemical Pathology
    • Clinical Informatics
    • Cytopathology
    • Dermatopathology
    • Forensic Pathology
    • Hematopathology
    • Medical Microbiology
    • Molecular Genetic Pathology
    • Neuropathology
    • Pediatric Pathology
    • Selective Pathology
    • Case Study
    • Other


    Poster Templates
    Please note, you will be required to use the pre-approved poster template for your poster submission. To download the templates click on the links below:


    The FSP will not be responsible for submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events. Faxed, emailed or mailed hard-copy posters or posters sent on a CD/disc WILL NOT be accepted. If you have questions, please contact the FSP office at posters@flpath.org or call 904-309-6204.







    Rare and Interesting Case Competition


    Pathology is hard! Every day, we are faced with challenging cases that require us to open books, read new articles, consult our friends and colleagues, and sometimes consult the experts. This year we are introducing something new for our annual FSP meeting to highlight these interesting cases and we need your help! 

    Community pathologists, junior faculty, and trainees with a faculty mentor are all encouraged to submit their rare and interesting cases for a chance to present at the FSP 2022 Annual Meeting.

    How to submit a case

    Please submit the information below as a short word document to education@flpath.org by December 9, 2021.

    • Name
    • Institution
    • Case title
    • A brief clinical summary/clinical history of case
    • A representative picture of an H&E stained slide as a jpg file
    • Key diagnostic points